P. R. Avery and A. C. Avery, Molecular methods to distinguish reactive and neoplastic lymphocyte expansions and their importance in transitional neoplastic states, Vet. Clin. Pathol, vol.33, pp.196-207, 2004.

F. Benchetrit, A. Ciree, V. Vives, G. Warnier, A. Gey et al., Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism, Blood, vol.99, pp.2114-2121, 2002.

M. Bonkobara, T. Saito, M. Yamashita, K. Tamura, H. Yagihara et al., Blastic natural killer cell leukaemia in a dog-a case report, Vet. J, vol.174, pp.659-662, 2007.

M. Bonkobara, T. Sato, N. Takahashi, Y. Kasahara, H. Yagihara et al., Characterization of cDNA and the genomic sequence encoding canine neural-cell adhesion molecule, CD56/N-CAM, Vet. Immunol. Immunopathol, vol.107, pp.171-176, 2005.

C. Bonnefont-rebeix, T. Marchal, J. Bernaud, J. J. Pin, C. Leroux et al., Toll-like receptor 3 (TLR3): a new marker of canine monocytes-derived dendritic cells (cMo-DC), Vet. Immunol. Immunopathol, vol.118, pp.134-139, 2007.

R. C. Burnett, W. Vernau, J. F. Modiano, C. S. Olver, P. F. Moore et al., Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes, Vet. Pathol, vol.40, pp.32-41, 2003.

J. K. Chan, W. Y. Tsang, and C. S. Ng, Clarification of CD3 immunoreactivity in nasal T/natural killer cell lymphomas: the neoplastic cells are often CD3 epsilon+, Blood, vol.87, pp.839-841, 1996.

A. Ciree, L. Michel, S. Camilleri-broet, F. Jean-louis, M. Oster et al., Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome), Int. J. Cancer, vol.112, pp.113-120, 2004.

B. Coiffier, M. Federico, D. Caballero, C. Dearden, F. Morschhauser et al., Therapeutic options in relapsed or refractory peripheral T-cell lymphoma, Cancer Treat. Rev, vol.40, pp.1080-1088, 2014.

M. A. Cooper, T. A. Fehniger, S. C. Turner, K. S. Chen, B. A. Ghaheri et al., Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset, Blood, vol.97, pp.3146-3151, 2001.

J. M. Coquet, S. Chakravarti, K. Kyparissoudis, F. W. Mcnab, L. A. Pitt et al., Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1. 1-NKT cell population, Proc. Natl. Acad. Sci. U. S. A, vol.105, pp.11287-11292, 2008.

Z. Dong, R. Kumar, X. Yang, and I. J. Fidler, Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma, Cell, vol.88, pp.801-810, 1997.

K. E. Drexler, Machine-phase nanotechnology, Sci. Am, vol.285, pp.74-75, 2001.

C. A. Ford, S. Petrova, J. D. Pound, J. J. Voss, L. Melville et al., Oncogenic properties of apoptotic tumor cells in aggressive B cell lymphoma, Curr. Biol, vol.25, pp.577-588, 2015.

F. Fossiez, O. Djossou, P. Chomarat, L. Flores-romo, S. Ait-yahia et al., T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines, J. Exp. Med, vol.183, pp.2593-2603, 1996.

C. Fournel-fleury, J. P. Magnol, P. Bricaire, T. Marchal, L. Chabanne et al., Cytohistological and immunological classification of canine malignant lymphomas: comparison with human non-Hodgkin's lymphomas, J. Comp. Pathol, vol.117, pp.35-59, 1997.

C. Fournel-fleury, F. Ponce, P. Felman, A. Blavier, C. Bonnefont et al., Canine T-cell lymphomas: a morphological, immunological, and clinical study of 46 new cases, Vet. Pathol, vol.39, pp.92-109, 2002.

H. Galkowska, L. O. Waldemar, and U. Wojewodzka, Reactivity of antibodies directed against human antigens with surface markers on canine leukocytes, Vet. Immunol. Immunopathol, vol.53, pp.329-334, 1996.

S. Gattenloehner, S. Chuvpilo, C. Langebrake, D. Reinhardt, H. K. Muller-hermelink et al., Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression, Blood, vol.110, pp.2027-2033, 2007.

H. Gill, R. H. Liang, E. Tse, M. Gooptu, R. Rhoades et al., Extranodal natural-killer/t-cell lymphoma, nasal type, Cancer Treat. Res, vol.165, pp.289-303, 2010.

C. Grondahl-rosado, T. B. Bonsdorff, H. C. Brun-hansen, and A. K. Storset, NCR1+ cells in dogs show phenotypic characteristics of natural killer cells, Vet. Res. Commun, vol.39, pp.19-30, 2015.

T. J. Gronski, R. L. Martin, D. K. Kobayashi, B. C. Walsh, M. C. Holman et al., Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase, J. Biol. Chem, vol.272, pp.12189-12194, 1997.

M. J. Gu and J. O. Ha, CD56 positive diffuse large B-cell lymphoma: a case report and literature review, Int. J. Clin. Exp. Pathol, vol.6, pp.3023-3025, 2013.

N. L. Harris, E. S. Jaffe, H. Stein, P. M. Banks, J. K. Chan et al., A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group, Blood, vol.84, pp.1361-1392, 1994.

S. C. Helfand, J. F. Modiano, P. F. Moore, S. A. Soergel, P. S. Macwilliams et al., Functional interleukin-2 receptors are expressed on natural killer-like leukemic cells from a dog with cutaneous lymphoma, Blood, vol.86, pp.636-645, 1995.

A. M. Houghton, J. L. Grisolano, M. L. Baumann, D. K. Kobayashi, R. D. Hautamaki et al., Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases, Cancer Res, vol.66, pp.6149-6155, 2006.

Y. Isobe, K. Sugimoto, K. Takeuchi, J. Ando, A. Masuda et al., Neural cell adhesion molecule (CD56)-positive B-cell lymphoma, Eur. J. Haematol, vol.79, pp.166-169, 2007.

E. S. Jaffe, Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, IARC, 2001.

S. Jain, X. Jirau-serrano, K. M. Zullo, L. Scotto, C. F. Palermo et al., Preclinical pharmacologic evaluation of pralatrexate and romidepsin confirms potent synergy of the combination in a murine model of human T-cell lymphoma, Clin. Cancer Res, vol.21, pp.2096-2106, 2015.

C. D. Jennings and K. A. Foon, Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy, Blood, vol.90, pp.2863-2892, 1997.

M. Jones, J. L. Cordell, A. D. Beyers, A. G. Tse, and D. Y. Mason, Detection of T and B cells in many animal species using cross-reactive anti-peptide antibodies, J. Immunol, vol.150, pp.5429-5435, 1993.

K. Kishibe, A. Katayama, Y. Harabuchi, K. Yoshino, T. Nagato et al., Program poster presentation: SP427 -expression of MMP-12 in nasal NK/T-cell lymphoma, Otolaryngol. Head Neck Surg, vol.141, p.218, 2009.

W. C. Kisseberth, M. V. Nadella, M. Breen, R. Thomas, S. E. Duke et al., A novel canine lymphoma cell line: a translational and comparative model for lymphoma research, Leuk. Res, vol.31, pp.1709-1720, 2007.

S. Kondraganti, S. Mohanam, S. K. Chintala, Y. Kin, S. L. Jasti et al., Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion, Cancer Res, vol.60, pp.6851-6855, 2000.

K. Lennert, Histologie des lymphomes malins non hodgkiniens selon la classification de Kiel actualisée, 1991.

Y. C. Lin, Y. C. Huang, Y. S. Wang, R. H. Juang, K. W. Liao et al., Canine CD8 T cells showing NK cytotoxic activity express mRNAs for NK cell-associated surface molecules, Vet. Immunol. Immunopathol, vol.133, pp.144-153, 2010.

H. Liu, M. Komai-koma, D. Xu, and F. Y. Liew, Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells, Proc. Natl. Acad. Sci. U. S. A, vol.103, pp.7048-7053, 2006.

L. Marconato, M. E. Gelain, and S. Comazzi, The dog as a possible animal model for human non-Hodgkin lymphoma: a review, Hematol. Oncol, vol.31, pp.1-9, 2013.

Y. Matsuo and H. G. Drexler, Immunoprofiling of cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma, Leuk. Res, vol.27, pp.935-945, 2003.

H. Matsuyama, H. I. Suzuki, H. Nishimori, M. Noguchi, T. Yao et al., miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma, Blood, vol.118, pp.6881-6892, 2011.

S. P. Mcdonough and P. F. Moore, Clinical, hematologic, and immunophenotypic characterization of canine large granular lymphocytosis, Vet. Pathol, vol.37, pp.637-646, 2000.

Y. Momoi, Y. Okai, T. Watari, R. Goitsuka, H. Tsujimoto et al., Establishment and characterization of a canine T-lymphoblastoid cell line derived from malignant lymphoma, Vet. Immunol. Immunopathol, vol.59, pp.11-20, 1997.

M. J. Moore, J. Hamm, J. Dancey, P. D. Eisenberg, M. Dagenais et al., Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the national cancer institute of canada clinical trials group, J. Clin. Oncol, vol.21, pp.3296-3302, 2003.

G. Murugaiyan and B. Saha, Protumor vs antitumor functions of IL-17, J. Immunol, vol.183, pp.4169-4175, 2009.

M. Nakaichi, Y. Taura, M. Kanki, K. Mamba, Y. Momoi et al., Establishment and characterization of a new canine B-cell leukemia cell line, J. Vet. Med. Sci, vol.58, pp.469-471, 1996.

M. Numasaki, J. Fukushi, M. Ono, S. K. Narula, P. J. Zavodny et al., Interleukin-17 promotes angiogenesis and tumor growth, Blood, vol.101, pp.2620-2627, 2003.

I. Otani, T. Niwa, M. Tajima, A. Ishikawa, T. Watanabe et al., CD56 is expressed exclusively on CD3+ T lymphocytes in canine peripheral blood, J. Vet. Med. Sci, vol.64, pp.441-444, 2002.

M. Pastor, K. Chalvet-monfray, T. Marchal, G. Keck, J. P. Magnol et al., Genetic and environmental risk indicators in canine non-Hodgkin's lymphomas: breed associations and geographic distribution of 608 cases diagnosed throughout France over 1 year, J. Vet. Intern. Med, vol.23, pp.301-310, 2009.

S. A. Pileri, M. Milani, G. Fraternali-orcioni, and E. Sabattini, From the R.E.A.L. Classification to the upcoming WHO scheme: a step toward universal categorization of lymphoma entities?, Ann. Oncol, vol.9, pp.607-612, 1998.

F. Ponce, T. Marchal, J. P. Magnol, V. Turinelli, D. Ledieu et al., A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology, Vet. Pathol, vol.47, pp.414-433, 2010.

V. Roth, Doubling time calculator, 2006.

B. C. Rutgen, S. E. Hammer, W. Gerner, M. Christian, A. G. De-arespacochaga et al., Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma, Leuk. Res, vol.34, pp.932-938, 2010.

F. Sandor and M. Buc, Toll-like receptors II. Distribution and pathways involved in TLR signalling, Folia Biol. (Praha), vol.51, pp.188-197, 2005.

S. D. Shapiro, D. K. Kobayashi, and T. J. Ley, Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages, J. Biol. Chem, vol.268, pp.23824-23829, 1993.

D. J. Shin, J. Y. Park, Y. Y. Jang, J. J. Lee, Y. K. Lee et al., Ex vivo expansion of canine cytotoxic large granular lymphocytes exhibiting characteristics of natural killer cells, Vet. Immunol. Immunopathol, vol.153, pp.249-259, 2013.

S. Sivori, M. Falco, S. Carlomagno, E. Romeo, L. Moretta et al., Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors, Int. Immunol, vol.19, pp.1341-1348, 2007.

S. Sivori, M. Falco, M. Della-chiesa, S. Carlomagno, M. Vitale et al., CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells, Proc. Natl. Acad. Sci. U. S. A, vol.101, pp.10116-10121, 2004.

T. J. Smith, K. Yamamoto, M. Kurata, A. Yukimori, S. Suzuki et al., Differential expression of Toll-like receptors in follicular lymphoma, diffuse large B-cell lymphoma and peripheral T-cell lymphoma, Exp. Mol. Pathol, vol.89, pp.284-290, 2010.

Z. Steplewski, K. A. Jeglum, C. Rosales, and N. Weintraub, Canine lymphoma-associated antigens defined by murine monoclonal antibodies, Cancer Immunol. Immunother, vol.24, pp.197-201, 1987.

S. E. Suter, M. B. Chein, V. Von-messling, B. Yip, R. Cattaneo et al., In vitro canine distemper virus infection of canine lymphoid cells: a prelude to oncolytic therapy for lymphoma, Clin. Cancer Res, vol.11, pp.1579-1587, 2005.
URL : https://hal.archives-ouvertes.fr/pasteur-00820027

S. H. Swerdlow, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, IARC, 2008.

V. Turinelli, T. Marchal, F. Ponce, C. Bonnefont-rebeix, and C. Fournel-fleury, Aggressive large granular lymphocyte lymphomas in five dogs: a clinical cytohistological and immunological study, Comp. Clin. Pathol, vol.13, pp.109-118, 2005.

S. Umeki, Y. Ema, R. Suzuki, M. Kubo, T. Hayashi et al., Establishment of five canine lymphoma cell lines and tumor formation in a xenotransplantation model, J. Vet. Med. Sci, vol.75, pp.467-474, 2013.

D. M. Vail and E. G. Macewen, Spontaneously occurring tumors of companion animals as models for human cancer, Cancer Invest, vol.18, pp.781-792, 2000.

V. E. Valli, M. San-myint, A. Barthel, D. Bienzle, J. Caswell et al., Classification of canine malignant lymphomas according to the world health organization criteria, Vet. Pathol, vol.48, pp.198-211, 2011.

C. J. Voskens, R. Watanabe, S. Rollins, D. Campana, K. Hasumi et al., Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicity, J. Exp. Clin. Cancer Res, vol.29, p.134, 2010.

J. Yamazaki, K. Baba, Y. Goto-koshino, A. Setoguchi-mukai, Y. Fujino et al., Quantitative assessment of minimal residual disease (MRD) in canine lymphoma by using real-time polymerase chain reaction, Vet. Immunol. Immunopathol, vol.126, pp.321-331, 2008.

Y. Yonemura, Y. Endo, H. Fujita, K. Kimura, K. Sugiyama et al., Inhibition of peritoneal dissemination in human gastric cancer by MMP-7-specific antisense oligonucleotide, J. Exp. Clin. Cancer Res, vol.20, pp.205-212, 2001.

S. Zucker, S. G. Eckhardt, and E. K. Rowinsky, Plasma MMPs as surrogates of BAY 12-9566, J. Clin. Oncol, vol.18, pp.1805-1806, 2000.